| Feature Story: |
Will Stemless Implants Dominate The Shoulder Arthroplasty Market? |
Shoulder implant design has been gradually evolving towards shorter implant stems since total shoulder arthroplasty results were first reported over 40 years ago. Reflecting a growing trend of minimally invasive surgeries, stemless arthroplasty is driven by the desire to facilitate smoother revision procedures, and to prevent stem-related complications.
According to a recent market study, the use of stemless implants in shoulder arthroplasty is growing, and it is expected to surpass the use of stemmed implants in Europe by the...
Click here to read more |
|
 Stryker has recently launched the arthroscopy market’s first reusable suture passer for rotator cuff repair, Cobra. The launch was initially announced at this year’s American Academy of Orthopaedic Surgeons (AAOS) conference.
The aptly named Cobra boasts novel needle manufacturing as well as an innovative jaw design to produce this first-of-its-kind reusable needle technology. According to a press release from Stryker, “Compared to other suture passers on the market, Cobra offers improved needle stiffness to address issues associated with intraoperative misfires and distal tip needle breakages. In addition, the value-based robust needle technology offers customers a...
read more}
|
|
|
|
 Orthofix International N.V., a global medical device company focused on musculoskeletal healing products and value added services, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its new internal fixation system, the G-Beam™ Fusion Beaming System.
Designed primarily for the treatment of Charcot foot, a debilitating condition where the bones in the foot weaken and collapse, the G-Beam devices can be implanted in the medial and lateral columns of the foot to provide alignment, stabilization and fixation.
“In my practice I often see patients whose uncontrolled diabetes has led to the development of...
read more}
|
|
 Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the launch of OsteGro, an allograft bone matrix that supports new bone growth in orthopedic surgical procedures. The launch of OsteGro further expands the company’s bone repair franchise.
“We are excited to add OsteGro to our innovative orthopedic surgery product line. OsteGro represents the third product in our portfolio which already includes ViBone, a viable bone matrix, and OsteSpine, a complete line of precision machined cervical spacers,” says Darryl Roberts, Ph.D., General Manager, Strategic Tissue Partnerships at Aziyo. “Our goal is to build an industry leading franchise in biologic materials for orthopedic surgery. This launch is yet another step towards...
read more}
|
|
 Orthofix International N.V., a global medical device company focused on musculoskeletal healing products and value added services, announced the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim™ bone growth stimulators.
The PhysioStim devices provide a non-surgical treatment option for patients who have a nonunion fracture to an extremity that has shown no visible signs of healing. These Class III medical devices use a pulsed electromagnetic field (PEMF) signal to induce a low-level electrical field at the fracture site which stimulates...
read more}
|
|
|
|
|
|
|
|
